Li Li

发表

Cardioprotective effects of alantolactone on isoproterenol-induced cardiac injury and cobalt chloride-induced cardiomyocyte injury

L. Chu, Panpan Liu, Miaomiao Liu, 2022, International journal of immunopathology and pharmacology.

Protective effects of safranal on hypoxia/reoxygenation-induced injury in H9c2 cardiac myoblasts via the PI3K/AKT/GSK3β signaling pathway

Hefei Wang, Hongfang Wang, Xue Han, 2021, Experimental and therapeutic medicine.

8-Gingerol Ameliorates Myocardial Fibrosis by Attenuating Reactive Oxygen Species, Apoptosis, and Autophagy via the PI3K/Akt/mTOR Signaling Pathway

L. Chu, Miaomiao Liu, Yu Liu, 2021, Frontiers in Pharmacology.

Protective mechanisms of 10-gingerol against myocardial ischemia may involve activation of JAK2/STAT3 pathway and regulation of Ca2+ homeostasis.

Qingzhong Jia, L. Chu, Yu Liu, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Liquiritigenin protects against myocardial ischemic by inhibiting oxidative stress, apoptosis, and L‐type Ca2+ channels

L. Chu, Jing Li, Xi Chu, 2022, Phytotherapy research : PTR.

Mechanisms of cinnamic aldehyde against myocardial ischemia/hypoxia injury in vivo and in vitro: Involvement of regulating PI3K/AKT signaling pathway.

L. Chu, Yu Liu, Xue Han, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Protective Effect of Danshen Zexie Decoction Against Non-Alcoholic Fatty Liver Disease Through Inhibition of ROS/NLRP3/IL-1β Pathway by Nrf2 Signaling Activation

Xue Han, Chenxu Liu, Ruilong Wang, 2022, Frontiers in Pharmacology.

Liquiritigenin protects against arsenic trioxide-induced liver injury by inhibiting oxidative stress and enhancing mTOR-mediated autophagy.

Yongchao Wu, L. Chu, Jianping Zhang, 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Hesperetin ameliorates ischemia/hypoxia‐induced myocardium injury via inhibition of oxidative stress, apoptosis, and regulation of Ca2+ homeostasis

L. Chu, Panpan Liu, Miaomiao Liu, 2022, Phytotherapy research : PTR.

Liquiritin Protects Against Cardiac Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway

Qingzhong Jia, Xue Han, Yucong Xue, 2022, Drug design, development and therapy.